A new blood test to monitor multiple sclerosis

Blood Draw

Currently, many neurologists do yearly MRIs to monitor multiple sclerosis disease activity. There is a new blood test that may monitor multiple sclerosis disease activity better in clinically stable patients. 

The test is called sNfL (serum neurofilament).  It measures the breakdown of a certain part of neurons, which occurs when multiple sclerosis is attacking the nervous system.  A recent study (https://nn.neurology.org/content/nnn/7/4/e714.full.pdf) shows that patients with low levels of sNfL have a very low probability of recent MS activity on yearly MRI. This new test may be a convenient alternative to MRI in monitoring disease activity.  

Tracy Fulton, MD Tracy Fulton, MD Tracy Fulton, MD Board Certified Neurologist

You Might Also Enjoy...